Clinical Study

Comparison of Second-Line Quadruple Therapies with or without Bismuth for Helicobacter pylori Infection

Table 3

Adverse events of the RBTM and RATM regimens.

Adverse eventsRBTM ()RATM () value

Diarrhea 2 (2/0/0)6 (5/1/0)0.28
Constipation0 (0/0/0)0 (0/0/0)ā€”
Abdominal pain3 (3/0/0)7 (5/2/0)0.25
Anorexia1 (1/0/0)2 (0/1/1)0.39
Nausea5 (5/0/0)12 (8/2/2)0.14
Vomiting6 (6/0/0)10 (8/1/1)0.46
Skin rash1 (1/0/0)2 (0/2/0)0.22
Headache1 (1/0/0)7 (6/1/0)0.08
Dizziness0 (0/0/0)8 (3/3/2)0.03
Bad taste2 (2/0/0)4 (2/2/0)0.35
Fatigue2 (2/0/0)5 (4/1/0)0.40
Others0 (0/0/0)4 (3/0/1)0.12

Total number of individual adverse events (number of different degrees of adverse events: 1/2/3).